Anavex Life Sciences
AVXL
#7563
Rank
โ‚น35.31 B
Marketcap
โ‚น395.28
Share price
-1.12%
Change (1 day)
-38.58%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น1.03 Billion

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are โ‚น1.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚น1.28 B23.05%
2023-09-30โ‚น1.04 B25.4%
2022-09-30โ‚น0.83 B3.68%
2021-09-30โ‚น0.80 B48.91%
2020-09-30โ‚น0.53 B50.65%
2019-09-30โ‚น0.35 B26.9%
2018-09-30โ‚น0.28 B20.32%
2017-09-30โ‚น0.23 B9.77%
2016-09-30โ‚น0.21 B22.31%
2015-09-30โ‚น0.17 B-60.61%
2014-09-30โ‚น0.44 B147.63%
2013-09-30โ‚น0.17 B17.12%
2012-09-30โ‚น0.15 B131.11%
2011-09-30โ‚น66.04 M-54.95%
2010-09-30โ‚น0.14 B-28.01%
2009-09-30โ‚น0.20 B90.21%
2008-09-30โ‚น0.10 B483.59%
2007-09-30โ‚น18.34 M1330.73%
2006-09-30โ‚น1.28 M8.04%
2005-09-30โ‚น1.18 M930.99%
2004-09-30โ‚น0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น47.30 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น74.95 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น17.22 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.90 B-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA